SAFETY OUTCOMES OF ORAL ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE

被引：0
|
作者：
Igamberdieva, Ranokhon [1 ]
Abdullaev, Sherzod [2 ]
机构：
[1] Tashkent Pediat Med Inst, Internal Med, Nephrol & Hemodialysis, Asian Origins Asia East Asia Southeast Asia, Tashkent, Uzbekistan
[2] Republican Sci & Pract Med Ctr Nephrol & Kidney T, Immunogenet, Asian Origins Asia East Asia Southeast Asia, Tashkent, Uzbekistan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
3896
引用
收藏
页码：I141 / I141
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of oral anticoagulant versus antiplatelet therapy for secondary prevention of cardiovascular disease in patients without atrial fibrillation
    Ricci, F.
    Ianni, U.
    Forcucci, F.
    Fedorowski, A.
    Zimarino, M.
    Gallina, S.
    Renda, G.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1517 - 1517
  • [42] Atrial Fibrillation in Patients with Chronic Kidney Disease
    Kotalczyk, Agnieszka
    Ding, Wern Yew
    Wong, Christopher F.
    Rao, Anirudh
    Gupta, Dhiraj
    Lip, Gregory Y. H.
    CARDIOLOGY CLINICS, 2021, 39 (03) : 435 - 446
  • [43] Improvements in oral anticoagulant therapy for atrial fibrillation
    Briongos Figuero, Sem
    Santos-Gallego, Carlos Garcia
    Badimon, Juan Jose
    MEDICINA CLINICA, 2013, 141 (11): : 487 - 493
  • [44] Response to "Direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease"
    Bhatia, Harpreet S.
    Bailey, Joseph
    Unlu, Ozan
    Hoffman, Katherine
    Kim, Robert J.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2020, 43 (02): : 267 - 267
  • [45] CARDIORENAL OUTCOMES ASSOCIATED WITH ORAL ANTICOAGULANT USE IN PATIENTS WITH ATRIAL FIBRILLATION
    Mazhar, Faizan
    Trevisan, Marco
    Hjemdahl, Paul
    Clase, Catherine M.
    De Jong, Y.
    Evans, Marie
    Bellocco, Rino
    Fu, Edouard
    Carrero, Juan Jesus
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I371 - I371
  • [46] The impact of anticoagulation therapy on kidney function in patients with atrial fibrillation and chronic kidney disease
    Simic, Jelena
    Mihajlovic, Miroslav
    Zec, Nevena
    Kovacevic, Vladan
    Marinkovic, Milan
    Mujovic, Nebojsa
    Potpara, Tatjana
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2023, 21 (12) : 937 - 945
  • [47] Effect of prevalent atrial fibrillation on cardiovascular outcomes in patients with chronic kidney disease
    Bhat, A.
    Gan, G.
    Chen, H. H. L.
    Gu, K.
    Denniss, M.
    Burgess, D. C.
    MacIntyre, R.
    Tan, T. C.
    EUROPEAN HEART JOURNAL, 2020, 41 : 494 - 494
  • [48] Role of chronic kidney disease and atrial fibrillation in outcomes of patients with ischemic stroke
    Khan, A. A.
    Lip, G. Y. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 (08) : 1009 - 1010
  • [49] Reasons for discontinuation of novel oral anticoagulant therapy in patients with atrial fibrillation
    Mitrovic, Darko
    Folkeringa, Richard
    Veeger, Nic
    van Roon, Eric
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (04) : 547 - 553
  • [50] Informing the Choice of Direct Oral Anticoagulant Therapy in Patients With Atrial Fibrillation
    Ferro, Enrico G.
    Kazi, Dhruv S.
    Zimetbaum, Peter J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (23): : 2372 - 2374
12345